Financials Shanghai Sanyou Medical Co., Ltd

Equities

End-of-day quote Shanghai S.E. Other stock markets 13/09/2024			5-day change	1st Jan Change
18.00 ^CNY	-1.59%		-0.99%	-7.69%

08-27	Shanghai Sanyou Medical Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2024	CI
08-15	Shanghai Sanyou Medical Co., Ltd acquired 55% stake in Shanghai Youhe Jicheng Medical Technology Co., Ltd. from Shanghai Boquan Equity Investment Management Co., Ltd. and Wuhu Boquan Qifei Equity Investment Partnership Enterprise (Limited Partnership) for CNY 30.5 million.	CI

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	390.4	593.4	649.2	460.7	559	699.5	879.5
Change	-	51.97%	9.4%	-29.04%	21.35%	25.13%	25.73%
EBITDA	149.8	229.9	259.7	170.6	-	-	-
Change	-	53.49%	12.97%	-34.31%	-100%	-	-
EBIT ¹	130.4	204	229.1	117.3	126.5	182.5	222.5
Change	-	56.48%	12.29%	-48.79%	7.82%	44.27%	21.92%
Interest Paid	-	-	-	-	-	-	-
Earnings before Tax (EBT) ¹	136.9	217.3	239.5	63.8	148	205	245
Change	-	58.7%	10.22%	-73.37%	131.97%	38.51%	19.51%
Net income ¹	118.6	186.4	190.8	129.9	110.5	152	180
Change	-	57.2%	2.39%	-31.92%	-14.94%	37.56%	18.42%
Announcement Date	02/02/21	21/02/22	21/02/23	23/02/24	-	-	-

¹CNY in Million

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026
Net Debt	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-
Announcement Date	02/02/21	21/02/22	21/02/23	23/02/24	-	-	-

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026
CAPEX ¹	30.45	91.29	138.2	25.79	543	510	478
Change	-	199.8%	51.38%	-81.34%	2,005.83%	-6.08%	-6.27%
Free Cash Flow (FCF) ¹	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-
Announcement Date	02/02/21	21/02/22	21/02/23	23/02/24	-	-	-

¹CNY in Million

Estimates

Fiscal Period: December	2018	2019	2020	2021	2022	2023	2024	2025	2026
Profitability
EBITDA Margin (%)	-	-	38.36%	38.74%	40%	37.03%	-	-	-
EBIT Margin (%)	-	-	33.39%	34.38%	35.29%	25.47%	22.63%	26.09%	25.3%
EBT Margin (%)	-	-	35.08%	36.63%	36.9%	13.85%	26.48%	29.31%	27.86%
Net margin (%)	-	-	30.37%	31.41%	29.39%	28.2%	19.77%	21.73%	20.47%
FCF margin (%)	-	-	-	-	-	-	-	-	-
FCF / Net Income (%)	-	-	-	-	-	-	-	-	-
Profitability
ROA	-	-	-	-	-	-	-	-	-
ROE	-	-	10.32%	11.6%	10.84%	4.87%	5.35%	6.9%	7.6%
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	-	-	7.8%	15.39%	21.29%	5.6%	97.14%	72.91%	54.35%
CAPEX / EBITDA (%)	-	-	20.33%	39.72%	53.22%	15.12%	-	-	-
CAPEX / FCF (%)	-	-	-	-	-	-	-	-	-
Items per share
Cash flow per share ¹	-	-	0.312	0.5833	0.6278	1.076	-0.01	0.435	0.955
Change	-	-	-	86.97%	7.63%	71.45%	-100.93%	-4,450%	119.54%
Dividend per Share ¹	-	-	0.1438	0.1504	-	-	-	-	-
Change	-	-	-	4.6%	-	-	-	-	-
Book Value Per Share ¹	-	-	6.174	6.785	7.405	7.69	8.015	8.465	9.005
Change	-	-	-	9.91%	9.13%	3.85%	4.23%	5.61%	6.38%
EPS ¹	-	-	0.5207	0.7521	0.7636	0.37	0.445	0.61	0.725
Change	-	-	-	44.45%	1.54%	-51.55%	20.27%	37.08%	18.85%
Nbr of stocks (in thousands)	-	-	248,454	248,454	248,454	248,454	248,454	248,454	248,454
Announcement Date	-	-	02/02/21	21/02/22	21/02/23	23/02/24	-	-	-